Illawarra-Shoalhaven Cancer Biobank

Registration Status: Completed
Objective:

The overall aim of the Illawarra-Shoalhaven Cancer Biobank is to assist researchers in conducting population-based studies investigating the genetic, cellular or biological, lifestyle and environmental factors associated with cancer and drug response.

Registered Biobank Name Illawarra-Shoalhaven Cancer Biobank
Biobank Leader Ashleigh Splitt
Principal Investigator A/Prof. Daniel Brungs
Address Loftus St
Wollongong, NSW, Australia
Website https://www.islhd.health.nsw.gov.au/services-clinics/illawarra-shoalhaven-cancer-biobank
Email for biobank inquiries ISLHD-IllawarraShoalhavenCancerBiobank@health.nsw.gov.au
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
 Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.
Biospecimen Collected: